chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain at the injection site for about 48 hours; low grade fever; mild chills; mild fatigue for a few hours; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site for about 48 hours), PYREXIA (low grade fever), CHILLS (mild chills) and FATIGUE (mild fatigue for a few hours) in a 40-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 3031279) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Patient was diagnosed with COVID-19) on 15-Jul-2022. Concomitant products included ACETAMINOPHEN for an unknown indication.    On 28-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) .5 milliliter. On 29-Sep-2023, the patient experienced VACCINATION SITE PAIN (Pain at the injection site for about 48 hours), PYREXIA (low grade fever), CHILLS (mild chills) and FATIGUE (mild fatigue for a few hours). On 30-Sep-2023, VACCINATION SITE PAIN (Pain at the injection site for about 48 hours), PYREXIA (low grade fever), CHILLS (mild chills) and FATIGUE (mild fatigue for a few hours) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.1 F.     The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use), the reporter did not provide any causality assessments.   The patient did not experience any additional symptoms/events.  No treatment information was provided.
pt recvd vax; pt devel weakness, fever & t 101; ppt had no appetite, & pain in stomach; lab tests revealed pos EBV titer of 640; pt tx w/ anacin;
This spontaneous report was received from a Registered Nurse referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 15-JUN-2017, the patient was inadvertently vaccinated with an expired dose of GARDASIL lot # M014929, expiration date on 27-MAY-2017 (strength, dose number, route and anatomical location were not provided) for prophylaxis. No adverse events reported. Additional information has been requested.
Client seen 06/29/2006. Client develop rash on face (cheek), eye lids.  Client developed conjunctivitis on 07/01/2006 and 07/02/2006, client was seen at private medical doctor on 07/05/2006.  Received CLINDAMYCIN cream and Doxycycline tablets to be taken for 2 weeks.  Client also took BENADRYL on 07/03/2006.  Rash clearing up by 07/07/2006.
After being given both shots, I became very hot, was seeing stars in front of me, and was severely dizzy,
Information has been received from a consumer concerning a female who was vaccinated with the first dose of Gardasil. Approximately two months after receiving the vaccine, the patient had an abnormal pap smear. The consumer considered the abnormal pap smear to be immediately life-threatening. This is one of two reports received from the same source.
He came in for his 2nd vaccine and had a case of shingles on his left flank. It had started on 5/15/21.
SPIKEVAX 12+ (COVID) 23-24 PFS      Severe incapacitating vertigo, vomiting, loss of balance, headache, low grade fever, chills, muscle pain, eye pain Prescribed 25 mg Meclizine 3x daily, 4 mg  Ondansetron every 6 hours Also took acetaminophen every 6 hours Severe vertigo and vomiting lasted about 4 hours until meds, reoccurred when time to take meds again, lingering dizziness, nausea, feeling  'off' 3 days after vaccine
Fainting spell 24OCT91 @ school 2nd day p/vax was given; c/o h/a, myalgia, rhinorrhea & cough x 24 hrs-36hrs probable concurrent;
Patient received a dose of Pfizer vaccine where the dose exceeded beyond use dating as determined by manufacturer by 5 days. As advised by Pfizer, they recommended that he receive an additional dose of vaccine as soon as possible to ensure appropriate protection. Patient was given this information and will schedule if feels it is necessary.
started feeling neausea and fatigue several hours after receiving the vaccine.  It is now 9 days later and I still have many issues.  I have fatigue, neausea, stomach ache, no appetite, slight runny nose and headaches.
Patient experienced eye swelling in the afternoon after receiving a flu vaccine.  She went to her primary care provider and was given a steroid injection.
Patient received GARDASIL vaccine in (L) upper arm. Patient developed small subdermal vesicle approx. 1 1/2" from injection site. Possible hive? Patient observed x 20 minutes and vesicle improved but did not resolve.
Headache, Arthralgia, Phlebitis & Fever Narrative: ~ Discomfort 3-4/10 to include Injection site (Onset after ~6-8hours post injection); Headache, Feverish/Chills, Joint/Body Aches. Symptoms seemed to subside with tylenol, and Advil, reduced after approx 26-28hours post injection. Mild+ in nature. Additional pronounced Redness at injection site 1 1/2 to 2inches x 3 1/2 to 4inches reduced in size after ~ 4-5 days
Vomiting, dizziness, fever, muscle aches, sore throat. Only vomiting twice on 12/23/09. Sore throat lasted 1-2 days. Fever lasted for 2 days. Muscle aches and dizziness continue, yet not as bad as first 3 days.
Patient states that he had pain on his left arm. Per patient, he walk in 10/19 w/ c/o pain on left arm d/t cheratussin medication. RN did not note that its due from the flu vaccine received 10/18.
Patient had a seizure 10 seconds after giving dose. Paramedics came and patient made full recovery.
felt terrible for about 36 hours; was sick for about 24 hours years ago; Initial information received on 15-Oct-2020 regarding an unsolicited valid non-serious case from a consumer (patient).   This case is linked to case ID: 2020SA292420, 2020SA292419, 2020SA292422, 2020SA292423, 2020SA292424, 2020SA292425, 2020SA292426, 2020SA292410, 2020SA292411, 2020SA292412, 2020SA292413, 2020SA292414, 2020SA292385, 2020SA292416, 2020SA292417, 2020SA292418, 2020SA292421.  This case involves a patient of unknown demographics who was sick for about 24 hours years ago (illness) and felt terrible for about 36 hours (feeling abnormal), after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiration date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick for about 24 hours years ago (illness) and felt terrible for about 36 hours (feeling abnormal), (non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information on the batch number for this case.
My son was being seen for his pre kindergarten exam. The lead pediatric nurse was training a med student during my sons exam. The student administered all of his shots. After administering several the lead nurse said the needle was dirty and she(the student) needed to repeat the dose again. They apologized for the additional poke and offered no information or concern of the effects of unsterile injections or repeated doses. They did offer an extra sticker.
she has been itching on her skin and it comes and goes./Itchy skin patches/appear in another place like on her leg; This is a spontaneous report from a contactable consumer(Patient). A 84-year-old Female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, ad-ministered in Upper Left arm on 30Jan2021 at 09:15 (at the age of 84-years-old) as 1st Dose, Single for COVID-19 immunization. The patient's Medical history included ongoing thyroid disorder. The patient's Concomitant medications included levothyroxine 0.75mg taken once daily ,taken for thyroid disorder from Start date in the 1970s, maybe 1974-1975 and ongoing. No History of all previous immunization with the Pfizer vaccine considered as suspect. No other vaccines administered on same date with the Pfizer vaccine considered as suspect. No Prior Vaccinations within 4 weeks of administration date of the suspect vaccine, No AE(s) following prior vaccinations. No Family Medical History Relevant to AEs. No Relevant Tests performed. About 21:00 on 30Jan2021,the patient experienced itching on her skin and it comes and goes, and sometime later appear in another place like on her leg; that the areas affected are variable .Itching is on different areas of her body but there is no rash. The event has just begun to improve today. There is no rash associated with the itchy skin patches. She asked if this is a normal reaction to the vaccine; and if she should or should not get the second dose as scheduled related to this event. If she does get the second dose and again experiences this event, are there any recommendations regarding treatment for the event. The patient did not visit any physician office/emergency room or was not hospitalized. The outcome for the event was recovering/resolving.  Follow-up attempts are completed. No further information is expected.
Rash after 10 min arm cheast and back. 25mg diphenhydramine given, 10mg Zyrtec given. monitored patient for 30 min and rash faded. Checked with allergy in dbq and Dr said not to give epi at this time as rxn improving and not to give 2nd dose.
Systemic: Anaphylaxis-Mild, Systemic: feelt tingling and warm sensation inside the body, felt tightness in throat; symptoms lasted 0 days
Fever of 101 for two days, excruciating head ache that was not cured by Excedrin, for 1 day, body aches all over body concentrated in all of and both of my arms, hips, legs; felt totally freezing when it was 70 degrees and needed heating blanket.
A non-serious spontaneous report of administration of expired dose was received from a health professional concerning a seven-year-old female. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 25-Dec-2011. On 27-Dec-2011, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
This spontaneous report was received from a nurse refers to a 21 year old non-female patient. Patient's pertinent medical history, drug reactions/allergies and concomitant medications were reported as "no". On 19-JAN-2018, the patient was vaccinated with 3rd dose of GARDASIL 9 (dose, unit and frequency not reported) (expiration date: 28-APR-2018 and lot number: M019923) intramuscularly in the left deltoid for the prevention of human papilloma virus. On 26-JAN-2018 (1 week later), patient was seen at the office because she developed a 2 cm lump that is painful to the touch at the injection site. Nurse reports that during that office visit the Physician determined that the lump was an injection site reaction, no induration, no erythema and no rash present. It was reported that no lab tests or studies were performed. The patient was treated for the events. Nurse reports that patient was treated with ice, heat and Ibuprofen (manufacturer unknown) without relief. Patient continues to follow-up with Physician for further unspecified treatment. The outcome of the events was reported as not recovered/not resolved.  Causality of the events was not reported.
pt brought to office 2 days p/vax w/ c/o screaming, dec appetite, mild fever
Tested positive for COVID.  Had a dry cough, congestion, and sneezing on 5/1/2021.
a positive COVID-19 test; a positive COVID-19 test; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). A 16-year-old male patient received BNT162b2 (BNT162B2), on 13Aug2021 as dose 1, single (Lot number: EY0584), in arm, on 04Sep2021 as dose 2, single (Lot number: FC3184), in arm and on 12Apr2022 as dose 3 (booster), single (Lot number: FK9893) at the age of 15 years, in arm for covid-19 immunisation. The patient's relevant medical history included: "Seasonal Allergies" (unspecified if ongoing), notes: Flonase as needy; "Tree Pollen" (unspecified if ongoing), notes: Flonase as needy; "Cats" (unspecified if ongoing), notes: Flonase as needy; "acute pancreatitis" (unspecified if ongoing), notes: acute pancreatitis was discontinued. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "a positive COVID-19 test". The patient underwent the following laboratory tests and procedures: Blood test: (19Jan2022) Unknown Results; Computerised tomogram: (19Jan2022) Unknown Results; Magnetic resonance imaging: (19Jan2022) Unknown Results; SARS-CoV-2 test: (19Jan2022) Positive, notes: Covid Positive loss of smell & Taste for Months; X-ray: (19Jan2022) Unknown Results.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300019688 same patient/vaccine, diff dose/event;
ONE DOSE WAS INADVERTENTLY ADMINISTERED THIS MORNING FROM PUNCTURED VIAL THAT WAS LEFT  IN REFRIGERATOR YESTERDAY; THE VIAL WAS LEFT IN THE FRIDGE PUNCTURED FOR AROUND 12 HOURS; This spontaneous report received from a pharmacist concerned a 30 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286 expiry: 06-SEP-2021) dose was not reported, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On JUL-2021, the subject experienced the vial was left in the fridge punctured for around 12 hours. On 09-JUL-2021, the subject experienced one dose was inadvertently administered this morning from punctured vial that was left in refrigerator yesterday. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the the vial was left in the fridge punctured for around 12 hours and one dose was inadvertently administered this morning from punctured vial that was left in refrigerator yesterday was not reported. This report was non-serious.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021 at 9:02 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 15-Apr-2021 at 9:02 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 45.16. Concomitant products were not provided. On 15-Apr-2021, Excursion time was 09 AM, temperature was 34, total doses given for the day was 188, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 06-Apr-2021, vial was moved to clinic on 15-Apr-2021. 18 vials were sent to clinic. Vaccine BUD date was 09-May-2021. On 15-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 34, 10 AM: 36, 11 AM: 38, 12 AM: 39, 1PM: 43, 2 PM: 44, 3 PM: 44, 4 PM: 42 and 5 PM: 42. On 16-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 9 AM: 50, 10 AM: 42, 11 AM: 44, 12 AM: 44, 1PM: 44, 2 PM: 44, 3 PM: 44, 4 PM: 44 and 5 PM: 44. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported.
Vaccination admin error- syringe broke when injecting, patient did not receive any vaccine.  Another dose was administered.
ARM SWOLLEN AND RED FROM INJECTION SITE TO ELBOW, SWOLLEN FOR 2-3 DAYS, PATIENT WENT TO LOCAL ER ON SAT 10/22 & ER PRESCRIBED 50 MG DIPHENHYDRAMINE, PATIENT ALSO WENT TO NURSE PRACTICIONER TUES 10/24 & WAS PRESCRIBED 5 DAY COURSE OF PREDNISONE 10MG, ONE TABLET DAILY FOR 5 DAYS.
Skin Rash, itchy discomfort on neck, arms, back, buttock areas. Treatment prescribed by physician was Levocetirizine 5mg tab  (1 tab x 30 days), Clobetasol Propionate ointment 0.05% applied topically, 1 app 2x/day 30 days.
BRIEF OVERVIEW: Admission Date: 9/5/2023 Discharge Date: Sep 7, 2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 72-year-old male with a past medical history of morbid obesity, type 2 diabetes, coronary artery disease, hypertension, hyperlipidemia, cardiomyopathy, OSA who presents to the emergency department with 24 hours of shortness of breath, cough, fever.  Symptoms developed day prior to admission.  Temperature in the emergency department was 101.7, blood pressure elevated, respiratory rate elevated.  Oxygen saturation was low when he was placed on 2 L nasal cannula.  She was found to test positive for COVID-19 in the emergency department.  Chest x-ray was unremarkable.  Complete blood count and CMP were unremarkable.  He was started on oral dexamethasone and IV remdesivir.  His oxygenation quickly improved to room air.  He was discharged home on 09/07/2023 with the hospital at home service to follow.  He was seen due to diabetes in the setting of steroids.  He had stable blood sugars.  He was discharged on his home dose of medicine.
papular itchy rash on lower back area.  Treated with prednisone 50 mg daily x 5 days, TAC ointment bid, cetirizine 10 mg qd, diphenhydramine 50 mg qhs.
Wife had symptoms on 9/11 and tested positive and I was negative. On 09/13 began having symptoms and tested positive on 09/14 and was prescribed PAXLOVID. After 2nd dose of PAXLOVID I became very nauseous. Tried to vomit and then couldn't stand up after. Was transferred to ER via ambulance. Had tachycardia, low blood pressure, and 70% pulse ox on room air. Placed IV and started high flow O2. BP and O2 sats both dropped again. Was admitted to the hospital. I was placed on IV antiviral and steroid. On 09/15 symptoms were improving and felt like eating that evening. On 09/16 received another dose of antiviral and steroid. On 09/17 I was feeling much better. Monitored heart for AFIB and I experienced none. Lungs were clear just not maintaining O2 sats well. I was released from hospital on 09/17. Was sent home on O2 and my need to use it has almost completely diminished.
Bi-lateral nosebleed, light headed, possible anaphylatic; Gave Epinepherine & DPH & sent to ER & pt was treated  & released 2 hrs later;
began experiencing tinnitus in my left ear approx 1 week after receiving the Pfizer booster (my second booster).  have beeb experiencing tinnitus since FEB 2022.
multiple brief, focal sz onset 24hr p/vax onset 24hr p/vax lasted 12hr;hosp 24hr;
Patient states became ill with headache, chills, fever, body aches and vomited x 1 about an hour and half after receiving shot. Pt called after hours and reported symptoms. Was advised to report to ER if symptoms persisted or worsened. Pt. reported to ER that evening.
Vision problems in right eye: Sudden onset of eye floaters and flashing light (semi-circle right side and lower left) in right eye.  No other symptoms.  Sought treatment the day after onset of symptoms from Dr. at Clinic. She used equipment to assess the condition of my eye and found that there were floaters but no retinal tears or separation. Advised to contact her in case symptoms worsened.
Patient came in w/mom secondary to concerns of localized superficial swelling lumps (bilateral thighs). Seen for 4 month well child visit and had vaccines on 6/17/14. She was seen by RN 6/26 and MD 6/27.
scattered vesicles in different stages of healing;atarax given PRN itching, aveeno, catamin
muscle ache at site of injection; diameter of the needle used was larger than typical/He adds that this was the size the facility told him they were using on him so it might sting a little bit more than normal; diameter of the needle used was larger than typical/He adds that this was the size the facility told him they were using on him so it might sting a little bit more than normal; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 24Feb2021 (Lot number: EN6202) at the age of 50 years as dose 1, single and administered in arm left, administration date 19Mar2021 (Lot number: EP7534) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 24Feb2021, outcome "unknown", described as "muscle ache at site of injection"; WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (non-serious), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (non-serious) all with onset 24Feb2021, outcome "unknown" and all described as "diameter of the needle used was larger than typical/He adds that this was the size the facility told him they were using on him so it might sting a little bit more than normal". Additional information: A couple of hours after the first injection, the patient had muscle ache at the injection site that went away completely unless he pushes hard on the area and can feel it weeks later. Both doses were administered at around 4 or 4:30 PM. The patient had no additional vaccines administered on the same day or prior vaccinations within 4 weeks. The events did not result in an emergency room or physician office visit.  No follow-up attempts are possible. No further information is expected.
forced air inj-jumped to one side-nervous rxn-bruise, 2" purple red raised center move arm;
pt recv vax 18SEP95 & 16APR96 pt exp scabs all over which was dx as chicken pox & a lack of response was indicated by an antibody titer taken that day which was less than 1 to 8;no further details were provided